McCarley & Cook Financial Planners’s Catalyst Pharmaceutical CPRX Stock Holding History

McCarley & Cook Financial Planners’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-20	Closed	-$629	–	277
2026 Q2	$629	Hold	20	–	–	﹤0.01%	242
2026 Q1	$495	Hold	20	–	–	﹤0.01%	255
2025 Q4	$467	Buy	+20	New	+$446	﹤0.01%	258

Other funds holding CPRX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

McCarley & Cook Financial Planners's CPRX Position: Q3 2026 in Review

McCarley & Cook Financial Planners sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 20 shares — an estimated $629 sold.

McCarley & Cook Financial Planners first reported a position in CPRX in Q4 2025 and held it in 3 quarters. The position peaked at $629 in Q2 2026. 1 fund tracked by Wall St. Rank holds CPRX as of Q3 2026.

McCarley & Cook Financial Planners reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
McCarley & Cook Financial Planners sold 20 Catalyst Pharmaceutical shares in Q3 2026, an estimated $629.
McCarley & Cook Financial Planners first reported a position in Catalyst Pharmaceutical in Q4 2025 and held it in 3 quarters.
McCarley & Cook Financial Planners's Catalyst Pharmaceutical position peaked at $629 in Q2 2026.
1 fund tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on McCarley & Cook Financial Planners's 13F filing for Q3 2026, filed 21 Oct 2026.